Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1989-02-27
1990-04-24
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 9, 435 4, 436 2, 436164, 436174, 436177, 436183, 436811, G01N 2178
Patent
active
049199153
ABSTRACT:
A method for detecting the ability of a compound to prevent development of red-to-green congophilic birefringence. The method is carried out by contacting the compound with dense microspheres which are derived from mammalian brain tissue and which, when disrupted, display red-to-green congophilic birefringence upon staining with Congo Red dye under conditions such that said dense microspheres are disrupted. Thereafter the disrupted dense microspheres are stained with Congo Red dye and any development of red-to-green congophilic birefringence in the stained disrupted dense microspheres is detected.
REFERENCES:
patent: 4666829 (1987-05-01), Glenner et al.
Averback, Acta Neuropathol. 61: 148-152 (1983).
Hara, J. Neuropath. Exp. Neurol. (1986).
Selkoe et al., Science 235: 873 (1987).
Graves & Kickhan, New England J. Med. 214: 782-783 (1936).
Wallace, The Lancet (Feb. 20, 1932), at 391-393.
Kennet et al., Curr. Top. Microbiol. Immunol. 81: 77-91 (1978).
Wisniewski et al., J. Neuropathol. & Exp. Neurol. 32: 566 (1973).
LandOfFree
Method for detecting the ability to prevent red-to-green congoph does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting the ability to prevent red-to-green congoph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting the ability to prevent red-to-green congoph will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-33502